OS Therapies Enters into Warrant Inducement Agreements
Stocks in this Quantisnow insightHealth Care
Historical context for OSTX
Across the 7 sessions after earlier OSTX headlines, the stock closed higher 4 times and lower 2 times, with a median move of 5.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | OSTX | SPY |
|---|---|---|---|
| Jan 5, 2026 | OS Therapies Provides First Half 2026 Corporate Outlook | +7.5% | +0.7% |
| Dec 15, 2025 | OS Therapies Announces Successful Type C Meeting with US FDA Regarding Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma | -7.7% | -0.2% |
| Dec 9, 2025 | OS Therapies Announces Successful pre-Marketing Authorisation Application Meeting with UK MHRA Regarding the Phase 2b Clinical Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma | +0.0% | -0.1% |
| Dec 5, 2025 | OS Therapies Announces FDA PDUFA Waiver & EMA Grants Union Marketing Authorisation Eligibility | +5.5% | +0.2% |
| Nov 25, 2025 | OS Therapies Receives Non-Proprietary Name 'daznelimgene lisbac' for OST-HER2 from World Health Organization | +4.7% | +0.9% |
| Nov 17, 2025 | OS Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update | -5.0% | -0.9% |
Keep researching OSTX
- What is Secondary offering?A sale of a public company's shares by existing holders such as founders or private equity, with proceeds going to the sellers, not the company.
- Shelf offerings and dilutionHow shelf registrations, 424B prospectus supplements, at-the-market programs and warrants work, and how to spot share dilution in SEC filings before it hits the stock.
- OSTX insider tradesEvery buy and sale reported by OS Therapies Incorporated officers, directors and large holders.
- OSTX financial statementsRevenue, profit, cash flow and balance sheet from OS Therapies Incorporated's SEC filings.
Quantisnow market dataAMEX
OSTX
OS Therapies Incorporated
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2024
Get push alerts for OSTX
Full OSTX profile on Quantisnow Follow OSTX and get a push notification the moment its next story breaks.